Navigating the safety profile of tramadol-paracetamol in chronic pain

Pain is multifaceted and may involve multiple mechanisms, supporting the use of analgesics with complementary pharmacological profiles. Combining tramadol and paracetamol may produce additive or synergistic analgesic effects while allowing lower doses of individual agents, potentially improving tolerability and reducing adverse effects. Paracetamol contributes rapid-onset, non-opioid analgesic activity associated with inhibition of prostaglandin synthesis in the central nervous system, while tramadol is a centrally acting analgesic with opioid properties that modulates ascending pain pathways and pain perception. Current evidence supports the use of the combination across several chronic pain conditions, including musculoskeletal pain, osteoarthritis, fibromyalgia, rheumatoid arthritis, and painful diabetic neuropathy. Reported benefits include reductions in pain intensity, improvements in physical function, sleep, mood, and health-related quality of life, as well as favorable tolerability in selected populations.

Tramadol plus paracetamol is a balanced multimodal approach to chronic pain, combining complementary mechanisms to achieve effective analgesia while potentially improving the safety and tolerability profile compared with higher-dose monotherapy.